President Jair Bolsonaro has criticized the terms of a deal proposed by Pfizer, saying it is overly onerous as it exempts the U.S. firm from potential liability for unforeseen problems. It dismissed any suggestion the move was politically motivated, saying the decision was purely technical. We had an external event that led to the regulator being notified, Gorinchteyn said. Four of them are from China. Pfizer has said other countries, including Brazil's neighbors in Latin America, have agreed to those terms.
President Jair Bolsonaro has criticized the terms of a deal published by Pfizer, saying it is overly onerous as it exempts the U.S. firm from potential public debate. Talking to the press is considered to be an asset.
( z0 multi-sentence :snt ( z1 criticize :ARG0 ( z2 person :name ( z3 name :op "Jair" :op "Bolsonaro" ) :ARG0-of ( z4 have-org-role :ARG2 ( z5 president ) ) ) :ARG1 ( z6 term :ARG0 ( z7 deal :ARG1-of ( z8 publish :ARG0 ( z9 company :name ( z10 name :op "Pfizer" ) ) ) ) ) :ARG2 ( z11 say :ARG0 z2 :ARG1 ( z12 onerous :ARG1-of ( z13 over ) :ARG1-of ( z14 cause :ARG0 ( z15 exempt :ARG0 z6 :ARG1 ( z16 firm :mod ( z17 country :name ( z18 name :op "U.S." ) ) ) :ARG2 ( z19 debate :ARG0 ( z20 public ) :mod ( z21 potential ) ) ) ) :domain z6 ) ) ) :snt ( z22 consider :ARG1 ( z23 asset :domain ( z24 talk :ARG2 ( z25 press ) ) ) ) )
(z0 / multi-sentence
    :snt1 (z1 / criticize-01
              :ARG0 (z2 / person
                        :name (z3 / name
                                  :op1 "Jair"
                                  :op2 "Bolsonaro")
                        :ARG0-of (z4 / have-org-role-91
                                     :ARG2 (z5 / president)))
              :ARG1 (z6 / term-01
                        :ARG0 (z7 / deal-01
                                  :ARG1-of (z8 / publish-01
                                               :ARG0 (z9 / company
                                                         :name (z10 / name
                                                                    :op1 "Pfizer")))))
              :ARG2 (z11 / say-01
                         :ARG0 z2
                         :ARG1 (z12 / onerous
                                    :ARG1-of (z13 / over-03)
                                    :ARG1-of (z14 / cause-01
                                                  :ARG0 (z15 / exempt-01
                                                             :ARG0 z6
                                                             :ARG1 (z16 / firm
                                                                        :mod (z17 / country
                                                                                  :name (z18 / name
                                                                                             :op1 "U.S.")))
                                                             :ARG2 (z19 / debate-01
                                                                        :ARG0 (z20 / public)
                                                                        :mod (z21 / potential))))
                                    :domain z6)))
    :snt2 (z22 / consider-01
               :ARG1 (z23 / asset
                          :domain (z24 / talk-01
                                       :ARG2 (z25 / press)))))
President Jair Bolsonaro has criticized the terms of a deal published by Pfizer , saying it is overly onerous as it exempts the U.S. firm from potential public debate . Talking to the press is considered to be an asset .
z4 :ARG2 z5
z2 :ARG0-of z4
z2 :name z3
z3 :op1 1
z3 :op2 0
z1 :ARG0 z2
z1 :ARG1 z6
z6 :ARG0 z7
z7 :ARG1-of z8
z8 :ARG0 z9
z9 :name z10
z10 :op1 2
z1 :ARG2 z11
z11 :ARG0 z2
z12 :ARG1-of z13
z11 :ARG1 z12
z12 :domain z6
z12 :ARG1-of z14
z14 :ARG0 z15
z15 :ARG0 z6
z17 :name z18
z18 :op1 3
z16 :mod z17
z15 :ARG1 z16
z19 :ARG0 z20
z19 :mod z21
z15 :ARG2 z19
z0 :snt1 z1
z24 :ARG2 z25
z0 :snt2 z22
z22 :ARG1 z23
z23 :domain z24